Recent Publications by Year

  • Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1  diabetes in the STAR 3 Study. Pediatric Diabetes 2012; 13: 6-11.
  • Tamborlane WV, Sikes KA. Insulin therapy in children and adolescents. Endocrine and Metabolism Clinics of North America. MAR-2012; 41(1): 145-160. 
  • DirecNet Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young  children aged 4 to <10 years. Diabetes Care 2012; 35: 204-210. 
  • DirecNet Study group. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.  Diabetes Care 2012; Feb 8. [Epub ahead of print]
  • JDRF CGM Study Group. Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset  Diabetes Care 2011;34: 586-590. 
  • JDRF CGM Study Group. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med 2011; 28:1118-1122.
  • DirecNet Study Group. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatric Diabetes 2011 Dec 13. doi: 10.1111/j.1399-5448.2011.00837.x. [Epub ahead of print].
  • Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV. New-generation diabetes management: glucose sensor-augmented insulin pump therapy. Expert Rev Med Devices 2011;8: 449–458. 
  • Cengiz E, Sherr JL, Erkin-Cakmak A, Weinzimer SA, Burke E, Sikes KA, Urban AD, Tamborlane WV. A bridge to pump therapy: bid regimen with NPH and detemir insulin during initial treatment of youth with type 1 diabetes (T1D). Endocrine Practice 2011; May 6:1-17.
  • JDRF CGM Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010; 33:1004-8. 
  • Ives B, Sikes K, Urban A, Stephenson K and Tamborlane W. Practical Aspects of Continuous Glucose Monitors: The experience of the Yale Children’s Diabetes Program. The Diabetes Educator. January/February 2010.
  • Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA. Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system. Diabetes Technol Ther 2009;11: 207-10. 
  • JDRF CGM Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32:1378-83.
  • JDRF CGM Study Group. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009; 32:1947-53.
  • The Diabetes Research in Children Network (DirecNet) Study Group. Blunted counter-regulatory hormone responses to hypoglycemia in young children and adolescents with   well-controlled type 1 diabetes. Diabetes Care 2009; 32: 1954-9. 
  • Sikes KA, Ives B, Sherr J, Urban A, Stephenson K, Tamborlane WV. Practical aspects of sensor augmented pump therapy with the Medtronic Paradigm Real Time systems: the experience of the yale children’s diabetes program. Infusystems USA VOL 6. No. 1 2009:1-4. 
  • JDRF CGM Study Group. Sustained benefit of continuous glucose monitoring on HbA1c, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009;32: 2047-9.
  • Weinzimer SA, Tamborlane WV. Sensor-augmented pump therapy in type 1 diabetes.  Current Opinion in Endocrinology, Diabetes, and Obesity 2008; 15: 118-122. 
  • Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.  Fully automated closed-loop insulin delivery vs. semi-automated hybrid control in pediatric patients with  type 1 diabetes using an artificial pancreas.  Diabetes Care 2008; 31: 934-939.  
  • JDRF CGM Study Group.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.  N Engl J Med 2008; 359: 1464-76.
  • Huo B, Steffen AT, Swan KJ, Sikes KA, Weinzimer SA, Tamborlane WV. Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes. Diabetes Care 2007;30:362-363.
  • The Diabetes Research in Children Network (DirecNet) Study Group. Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes.Pediatric Diabetes 2007: 8: 199–205. 
  • The Diabetes Research in Children Network (DirecNet) Study Group. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006; 29(1): 20-5. 
  • Springer D, Dziura J, Tamborlane WV,. Steffen AT, Ahern JH, Vincent M, Weinzimer SA. Optimal control of type 1 diabetes in youth receiving intensive treatment. J Pediatr 2006; 149: 227-232.
  • The Diabetes Research in Children Network (DirecNet) Study Group. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006; 29: 2200-2204.
  • Weinzimer SA; Swan KL; Sikes KA; Ahern JH. Emerging evidence for the use of insulin pump therapy in infants, toddlers and pre-school age children with type 1 diabetes. Pediatric Diabetes 01-AUG-2006; 7 Suppl 4: 15-9.
  • Tamborlane WV; Swan K; Sikes KA; Steffen AT; Weinzimer SA. The renaissance of insulin pump treatment in childhood type 1 diabetes. Reviews in endocrine & metabolic disorders 01-SEP-2006; 7(3): 205-13.
  • Tamborlane WV; Sikes KA; Steffen AT; Weinzimer SA. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes Diabetes research and clinical practice 01-DEC-2006; 74 Suppl 2: S112-5
  • Urban, AD, & Grey M. Type 1 Diabetes. (2006). Type 1 Diabetes. Nursing Clinics of North America, 41(4): 513-5130.
  • The Diabetes Research in Children Network (DirecNet) Study Group: Impact of exercise on overnight glycemic control in children with type 1 diabetes. J Pediatr 2005; 147: 528-534. 
  • Weinzimer SA, Sikes KA, Steffen AT, Tamborlane WV. Insulin pump treatment of childhood type 1 diabetes. Pediatric Clinics of North America 01-DEC-2005; 52(6): 1677-88.
  • Sikes KA, Ahern J, Weinzimer SA, Tamborlane WV. Practical aspects of insulin pump therapy in children with diabetes: the Yale experience. InfusystemsUSA VOL 2. No. 4 2005: 25-28.